Research Article

Tyrosinase Inhibitory Activity, 3D QSAR, and Molecular Docking Study of 2,5-Disubstituted-1,3,4-Oxadiazoles

Table 4

Selected descriptors, actual and predicted activity of tyrosinase inhibitors.

CompoundDescriptorsActivity
S_793S_757E_550ActualPredictedResidue

** 4a−0.0063117.920552.0790881.1821291.325233−0.1431
4b−0.0055710.99283−0.79360.9498780.992882−0.043
4c−0.0074320.208072.1512231.6075621.5335830.073979
4d−0.0074320.208072.1512231.5578681.5335830.024285
4e−0.00651301.9273361.5810391.5698360.011203
4f−0.0057419.12609−1.805361.0799041.131727−0.05182
4g−0.0062918.094683.1323911.2457591.361143−0.11538
** 4h−0.0057410.46793−0.807661.59891.0075270.591373
** 4i−0.0074419.835724.2671131.553641.600056−0.04642
4j−0.0074419.835724.2671131.5290451.600056−0.07101
4k−0.0065430−5.242571.269981.331729−0.06175
4l−0.007630−5.366611.5126841.4838610.028823
4m−0.00607302.5703451.6142641.5273440.08692
4n−0.00696.3836753.1568991.345571.237790.10778
** 4o−0.0077217.788551.6607191.45241.516313−0.06391
4p−0.0077217.788551.6607191.4992751.516313−0.01704
4q−0.00673301.1708051.5393271.577306−0.03798
4r−0.00787301.0068011.6805171.73882−0.0583
4s−0.0063730−2.434341.8525541.8059040.097768
4t−0.0069430−2.224931.7826291.6943160.025586

**Test set compounds.